431 results on '"Vissers, L.E.L.M."'
Search Results
2. Clinical genome interpretation: hidden variants and non-coding variation
- Author
-
Vissers, L.E.L.M., Brunner, H.G., Hoischen, A., Sanden, P.G.H. van der, Vissers, L.E.L.M., Brunner, H.G., Hoischen, A., and Sanden, P.G.H. van der
- Abstract
Contains fulltext : 306761.pdf (Publisher’s version ) (Open Access), Radboud University, 13 juni 2024, Promotores : Vissers, L.E.L.M., Brunner, H.G. Co-promotor : Hoischen, A., 241 p.
- Published
- 2024
3. Next-generation phenotyping in neurodevelopmental disorders: Applications of artificial intelligence in clinical genetics
- Author
-
Vries, L.B.A. de, Gerven, M.A.J. van, Vissers, L.E.L.M., Hinne, M., Dingemans, A.J.M., Vries, L.B.A. de, Gerven, M.A.J. van, Vissers, L.E.L.M., Hinne, M., and Dingemans, A.J.M.
- Abstract
Contains fulltext : 306760.pdf (Publisher’s version ) (Open Access), Radboud University, 12 juni 2024, Promotores : Vries, L.B.A. de, Gerven, M.A.J. van, Vissers, L.E.L.M. Co-promotor : Hinne, M., 236 p.
- Published
- 2024
4. Refining the 9q34.3 microduplication syndrome reveals mild neurodevelopmental features associated with a distinct global DNA methylation profile.
- Author
-
Rots, D., Rooney, K., Relator, R., Kerkhof, J., McConkey, H., Pfundt, R.P., Marcelis, C.L.M., Willemsen, M.H., Hagen, J.M. van, Zwijnenburg, P., Alders, M., Õunap, K., Reimand, T., Fjodorova, O., Berland, S., Liahjell, E.B., Bojovic, O., Kriek, M., Ruivenkamp, C., Bonati, M.T., Brunner, H.G., Vissers, L.E.L.M., Sadikovic, B., Kleefstra, T., Rots, D., Rooney, K., Relator, R., Kerkhof, J., McConkey, H., Pfundt, R.P., Marcelis, C.L.M., Willemsen, M.H., Hagen, J.M. van, Zwijnenburg, P., Alders, M., Õunap, K., Reimand, T., Fjodorova, O., Berland, S., Liahjell, E.B., Bojovic, O., Kriek, M., Ruivenkamp, C., Bonati, M.T., Brunner, H.G., Vissers, L.E.L.M., Sadikovic, B., and Kleefstra, T.
- Abstract
Contains fulltext : 306427.pdf (Publisher’s version ) (Open Access), Precise regulation of gene expression is important for correct neurodevelopment. 9q34.3 deletions affecting the EHMT1 gene result in a syndromic neurodevelopmental disorder named Kleefstra syndrome. In contrast, duplications of the 9q34.3 locus encompassing EHMT1 have been suggested to cause developmental disorders, but only limited information has been available. We have identified 15 individuals from 10 unrelated families, with 9q34.3 duplications <1.5 Mb in size, encompassing EHMT1 entirely. Clinical features included mild developmental delay, mild intellectual disability or learning problems, autism spectrum disorder, and behavior problems. The individuals did not consistently display dysmorphic features, congenital anomalies, or growth abnormalities. DNA methylation analysis revealed a weak DNAm profile for the cases with 9q34.3 duplication encompassing EHMT1, which could segregate the majority of the affected cases from controls. This study shows that individuals with 9q34.3 duplications including EHMT1 gene present with mild non-syndromic neurodevelopmental disorders and DNA methylation changes different from Kleefstra syndrome., 01 juni 2024
- Published
- 2024
5. Optical genome mapping and revisiting short-read genome sequencing data reveal previously overlooked structural variants disrupting retinal disease-associated genes.
- Author
-
Bruijn, S.E. de, Rodenburg, K., Corominas, J., Ben-Yosef, T., Reurink, J.A., Kremer, H., Whelan, L., Plomp, A.S., Berger, W., Farrar, G.J., Ferenc Kovács, Á., Fajardy, I., Hitti-Malin, R.J., Weisschuh, N., Weener, M.E., Sharon, D., Pennings, R.J.E., Haer-Wigman, L., Hoyng, C.B., Nelen, M.R., Vissers, L.E.L.M., Born, L.I. van den, Gilissen, C.F.H.A., Cremers, F.P.M., Hoischen, A., Neveling, K., Roosing, S., Bruijn, S.E. de, Rodenburg, K., Corominas, J., Ben-Yosef, T., Reurink, J.A., Kremer, H., Whelan, L., Plomp, A.S., Berger, W., Farrar, G.J., Ferenc Kovács, Á., Fajardy, I., Hitti-Malin, R.J., Weisschuh, N., Weener, M.E., Sharon, D., Pennings, R.J.E., Haer-Wigman, L., Hoyng, C.B., Nelen, M.R., Vissers, L.E.L.M., Born, L.I. van den, Gilissen, C.F.H.A., Cremers, F.P.M., Hoischen, A., Neveling, K., and Roosing, S.
- Abstract
Item does not contain fulltext, PURPOSE: Structural variants (SVs) play an important role in inherited retinal diseases (IRD). Although the identification of SVs significantly improved upon the availability of genome sequencing, it is expected that involvement of SVs in IRDs is higher than anticipated. We revisited short-read genome sequencing data to enhance the identification of gene-disruptive SVs. METHODS: Optical genome mapping was performed to improve SV detection in short-read genome sequencing-negative cases. In addition, reanalysis of short-read genome sequencing data was performed to improve the interpretation of SVs and to re-establish SV prioritization criteria. RESULTS: In a monoallelic USH2A case, optical genome mapping identified a pericentric inversion (173 megabase), with 1 breakpoint disrupting USH2A. Retrospectively, the variant could be observed in genome sequencing data but was previously deemed false positive. Reanalysis of short-read genome sequencing data (427 IRD cases) was performed which yielded 30 pathogenic SVs affecting, among other genes, USH2A (n = 15), PRPF31 (n = 3), and EYS (n = 2). Eight of these (>25%) were overlooked during previous analyses. CONCLUSION: Critical evaluation of our findings allowed us to re-establish and improve our SV prioritization and interpretation guidelines, which will prevent missing pathogenic events in future analyses. Our data suggest that more attention should be paid to SV interpretation and the current contribution of SVs in IRDs is still underestimated.
- Published
- 2023
6. The Genetics of Intellectual Disability.
- Author
-
Jansen, S, Vissers, L.E.L.M., Vries, B.B. de, Jansen, S, Vissers, L.E.L.M., and Vries, B.B. de
- Abstract
Item does not contain fulltext, Intellectual disability (ID) has a prevalence of ~2-3% in the general population, having a large societal impact. The underlying cause of ID is largely of genetic origin; however, identifying this genetic cause has in the past often led to long diagnostic Odysseys. Over the past decades, improvements in genetic diagnostic technologies and strategies have led to these causes being more and more detectable: from cytogenetic analysis in 1959, we moved in the first decade of the 21st century from genomic microarrays with a diagnostic yield of ~20% to next-generation sequencing platforms with a yield of up to 60%. In this review, we discuss these various developments, as well as their associated challenges and implications for the field of ID, which highlight the revolutionizing shift in clinical practice from a phenotype-first into genotype-first approach.
- Published
- 2023
7. The performance of genome sequencing as a first-tier test for neurodevelopmental disorders.
- Author
-
Sanden, B. van der, Schobers, G.M.G., Corominas-Galbany, J., Koolen, D.A., Sinnema, M., Reeuwijk, J. van, Stumpel, C.T., Kleefstra, T., Vries, B.B. de, Ruiterkamp-Versteeg, M., Leijsten, N., Kwint, M.P., Derks, R.C., Swinkels, H.L., Ouden, A.P.M. den, Pfundt, R.P., Rinne, T.K., Leeuw, N. de, Stegmann, A.P.A., Stevens, S.J.C., Wijngaard, A. van den, Brunner, H.G., Yntema, H.G., Gilissen, C., Nelen, M.R., Vissers, L.E.L.M., Sanden, B. van der, Schobers, G.M.G., Corominas-Galbany, J., Koolen, D.A., Sinnema, M., Reeuwijk, J. van, Stumpel, C.T., Kleefstra, T., Vries, B.B. de, Ruiterkamp-Versteeg, M., Leijsten, N., Kwint, M.P., Derks, R.C., Swinkels, H.L., Ouden, A.P.M. den, Pfundt, R.P., Rinne, T.K., Leeuw, N. de, Stegmann, A.P.A., Stevens, S.J.C., Wijngaard, A. van den, Brunner, H.G., Yntema, H.G., Gilissen, C., Nelen, M.R., and Vissers, L.E.L.M.
- Abstract
01 januari 2023, Item does not contain fulltext, Genome sequencing (GS) can identify novel diagnoses for patients who remain undiagnosed after routine diagnostic procedures. We tested whether GS is a better first-tier genetic diagnostic test than current standard of care (SOC) by assessing the technical and clinical validity of GS for patients with neurodevelopmental disorders (NDD). We performed both GS and exome sequencing in 150 consecutive NDD patient-parent trios. The primary outcome was diagnostic yield, calculated from disease-causing variants affecting exonic sequence of known NDD genes. GS (30%, n = 45) and SOC (28.7%, n = 43) had similar diagnostic yield. All 43 conclusive diagnoses obtained with SOC testing were also identified by GS. SOC, however, required integration of multiple test results to obtain these diagnoses. GS yielded two more conclusive diagnoses, and four more possible diagnoses than ES-based SOC (35 vs. 31). Interestingly, these six variants detected only by GS were copy number variants (CNVs). Our data demonstrate the technical and clinical validity of GS to serve as routine first-tier genetic test for patients with NDD. Although the additional diagnostic yield from GS is limited, GS comprehensively identified all variants in a single experiment, suggesting that GS constitutes a more efficient genetic diagnostic workflow.
- Published
- 2023
8. Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction
- Author
-
Reurink, J.A., Weisschuh, Nicole, Garanto, A., Dockery, A., Born, L.I. van den, Fajardy, Isabelle, Haer-Wigman, L., Klaver, C.C.W., Smits, J.J., Pennings, R.J.E., Aben, M.J., Oostrik, J., Astuti, G.D.N, Corominas, J., Phan, M., Zelst-Stams, W.A.G. van, Bruijn, S.E. de, Li, C.H.Z., Hoyng, C.B., Gilissen, C.F.H.A., Vissers, L.E.L.M., Cremers, F.P.M., Kremer, H., WIjk, E. van, Roosing, S., Reurink, J.A., Weisschuh, Nicole, Garanto, A., Dockery, A., Born, L.I. van den, Fajardy, Isabelle, Haer-Wigman, L., Klaver, C.C.W., Smits, J.J., Pennings, R.J.E., Aben, M.J., Oostrik, J., Astuti, G.D.N, Corominas, J., Phan, M., Zelst-Stams, W.A.G. van, Bruijn, S.E. de, Li, C.H.Z., Hoyng, C.B., Gilissen, C.F.H.A., Vissers, L.E.L.M., Cremers, F.P.M., Kremer, H., WIjk, E. van, and Roosing, S.
- Abstract
Item does not contain fulltext
- Published
- 2023
9. De novo mutation hotspots in homologous protein domains identify function-altering mutations in neurodevelopmental disorders
- Author
-
Wiel, L., Hampstead, J.E., Venselaar, H., Vissers, L.E.L.M., Brunner, H.G., Pfundt, R.P., Vriend, Gerrit, Veltman, J.A., Gilissen, C., Wiel, L., Hampstead, J.E., Venselaar, H., Vissers, L.E.L.M., Brunner, H.G., Pfundt, R.P., Vriend, Gerrit, Veltman, J.A., and Gilissen, C.
- Abstract
Item does not contain fulltext
- Published
- 2023
10. Comprehensive de novo mutation discovery with HiFi long-read sequencing.
- Author
-
Kucuk, E., Sanden, B. van der, O'Gorman, L., Kwint, M.P., Derks, R.C., Wenger, A.M., Lambert, C., Chakraborty, S., Baybayan, P., Rowell, W.J., Brunner, H.G., Vissers, L.E.L.M., Hoischen, A., Gilissen, C., Kucuk, E., Sanden, B. van der, O'Gorman, L., Kwint, M.P., Derks, R.C., Wenger, A.M., Lambert, C., Chakraborty, S., Baybayan, P., Rowell, W.J., Brunner, H.G., Vissers, L.E.L.M., Hoischen, A., and Gilissen, C.
- Abstract
Contains fulltext : 292751.pdf (Publisher’s version ) (Open Access), BACKGROUND: Long-read sequencing (LRS) techniques have been very successful in identifying structural variants (SVs). However, the high error rate of LRS made the detection of small variants (substitutions and short indels < 20 bp) more challenging. The introduction of PacBio HiFi sequencing makes LRS also suited for detecting small variation. Here we evaluate the ability of HiFi reads to detect de novo mutations (DNMs) of all types, which are technically challenging variant types and a major cause of sporadic, severe, early-onset disease. METHODS: We sequenced the genomes of eight parent-child trios using high coverage PacBio HiFi LRS (~ 30-fold coverage) and Illumina short-read sequencing (SRS) (~ 50-fold coverage). De novo substitutions, small indels, short tandem repeats (STRs) and SVs were called in both datasets and compared to each other to assess the accuracy of HiFi LRS. In addition, we determined the parent-of-origin of the small DNMs using phasing. RESULTS: We identified a total of 672 and 859 de novo substitutions/indels, 28 and 126 de novo STRs, and 24 and 1 de novo SVs in LRS and SRS respectively. For the small variants, there was a 92 and 85% concordance between the platforms. For the STRs and SVs, the concordance was 3.6 and 0.8%, and 4 and 100% respectively. We successfully validated 27/54 LRS-unique small variants, of which 11 (41%) were confirmed as true de novo events. For the SRS-unique small variants, we validated 42/133 DNMs and 8 (19%) were confirmed as true de novo event. Validation of 18 LRS-unique de novo STR calls confirmed none of the repeat expansions as true DNM. Confirmation of the 23 LRS-unique SVs was possible for 19 candidate SVs of which 10 (52.6%) were true de novo events. Furthermore, we were able to assign 96% of DNMs to their parental allele with LRS data, as opposed to just 20% with SRS data. CONCLUSIONS: HiFi LRS can now produce the most comprehensive variant dataset obtainable by a single technology in a single laboratory
- Published
- 2023
11. A complex structural variant near SOX3 causes X-linked split-hand/foot malformation.
- Author
-
Boer, E. de, Marcelis, C.L., Neveling, K., Beusekom, E. van, Hoischen, A., Klein, W.M., Leeuw, N. de, Mantere, T., Melo, U.S., Reeuwijk, J. van, Smeets, D.F., Spielmann, M., Kleefstra, T., Bokhoven, H. van, Vissers, L.E.L.M., Boer, E. de, Marcelis, C.L., Neveling, K., Beusekom, E. van, Hoischen, A., Klein, W.M., Leeuw, N. de, Mantere, T., Melo, U.S., Reeuwijk, J. van, Smeets, D.F., Spielmann, M., Kleefstra, T., Bokhoven, H. van, and Vissers, L.E.L.M.
- Abstract
Contains fulltext : 293172.pdf (Publisher’s version ) (Open Access), Split-hand/foot malformation (SHFM) is a congenital limb defect most typically presenting with median clefts in hands and/or feet, that can occur in a syndromic context as well as in isolated form. SHFM is caused by failure to maintain normal apical ectodermal ridge function during limb development. Although several genes and contiguous gene syndromes are implicated in the monogenic etiology of isolated SHFM, the disorder remains genetically unexplained for many families and associated genetic loci. We describe a family with isolated X-linked SHFM, for which the causative variant could be detected after a diagnostic journey of 20 years. We combined well-established approaches including microarray-based copy number variant analysis and fluorescence in situ hybridization coupled with optical genome mapping and whole genome sequencing. This strategy identified a complex structural variant (SV) comprising a 165-kb gain of 15q26.3 material ([GRCh37/hg19] chr15:99795320-99960362dup) inserted in inverted position at the site of a 38-kb deletion on Xq27.1 ([GRCh37/hg19] chrX:139481061-139518989del). In silico analysis suggested that the SV disrupts the regulatory framework on the X chromosome and may lead to SOX3 misexpression. We hypothesize that SOX3 dysregulation in the developing limb disturbed the fine balance between morphogens required for maintaining AER function, resulting in SHFM in this family.
- Published
- 2023
12. The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder.
- Author
-
Rots, D., Jakub, T.E., Keung, C., Jackson, A., Banka, S., Pfundt, R.P., Vries, B.B.A. de, Jaarsveld, R.H. van, Hopman, S.M.J., Binsbergen, E. van, Valenzuela, I., Hempel, M., Bierhals, T., Kortüm, F., Lecoquierre, F., Goldenberg, A., Hertz, J.M., Andersen, C.B., Kibæk, M., Prijoles, E.J., Stevenson, R.E., Everman, D.B., Patterson, W.G., Meng, L., Gijavanekar, C., Dios, K. De, Lakhani, S., Levy, T., Wagner, M., Wieczorek, D., Benke, P.J., Lopez Garcia, M.S., Perrier, R., Sousa, S.B., Almeida, P.M., Simões, M.J., Isidor, B., Deb, W., Schmanski, A.A., Abdul-Rahman, O., Philippe, C., Bruel, A.L., Faivre, L., Vitobello, A., Thauvin, C., Smits, J.J., Garavelli, L., Caraffi, S.G., Peluso, F., Davis-Keppen, L., Platt, D., Royer, E., Leeuwen, L van, Sinnema, M., Stegmann, A.P.A., Stumpel, C.T., Tiller, G.E., Bosch, D.G.M., Potgieter, S.T., Joss, S., Splitt, M., Holden, S., Prapa, M., Foulds, N., Douzgou, S., Puura, K., Waltes, R., Chiocchetti, A.G., Freitag, C.M., Satterstrom, F.K., Rubeis, S. de, Buxbaum, J., Gelb, B.D., Branko, A., Kushima, I., Howe, J., Scherer, S.W., Arado, A., Baldo, C., Patat, O., Bénédicte, D., Lopergolo, D., Santorelli, F.M., Haack, T.B., Dufke, A., Bertrand, M., Falb, R.J., Rieß, A., Krieg, P., Spranger, S., Bedeschi, M.F., Iascone, M., Josephi-Taylor, S., Roscioli, T., Buckley, M.F., Liebelt, J., Dagli, A.I., Aten, E., Hurst, A.C.E., Hicks, A., Suri, M., Aliu, E., Naik, S., Sidlow, R., Coursimault, J., Nicolas, G., Küpper, H., Petit, F., Ibrahim, V., Top, D., Cara, F. Di, Louie, R.J., Stolerman, E., Brunner, H.G., Vissers, L.E.L.M., Kramer, J.M., Kleefstra, T., Rots, D., Jakub, T.E., Keung, C., Jackson, A., Banka, S., Pfundt, R.P., Vries, B.B.A. de, Jaarsveld, R.H. van, Hopman, S.M.J., Binsbergen, E. van, Valenzuela, I., Hempel, M., Bierhals, T., Kortüm, F., Lecoquierre, F., Goldenberg, A., Hertz, J.M., Andersen, C.B., Kibæk, M., Prijoles, E.J., Stevenson, R.E., Everman, D.B., Patterson, W.G., Meng, L., Gijavanekar, C., Dios, K. De, Lakhani, S., Levy, T., Wagner, M., Wieczorek, D., Benke, P.J., Lopez Garcia, M.S., Perrier, R., Sousa, S.B., Almeida, P.M., Simões, M.J., Isidor, B., Deb, W., Schmanski, A.A., Abdul-Rahman, O., Philippe, C., Bruel, A.L., Faivre, L., Vitobello, A., Thauvin, C., Smits, J.J., Garavelli, L., Caraffi, S.G., Peluso, F., Davis-Keppen, L., Platt, D., Royer, E., Leeuwen, L van, Sinnema, M., Stegmann, A.P.A., Stumpel, C.T., Tiller, G.E., Bosch, D.G.M., Potgieter, S.T., Joss, S., Splitt, M., Holden, S., Prapa, M., Foulds, N., Douzgou, S., Puura, K., Waltes, R., Chiocchetti, A.G., Freitag, C.M., Satterstrom, F.K., Rubeis, S. de, Buxbaum, J., Gelb, B.D., Branko, A., Kushima, I., Howe, J., Scherer, S.W., Arado, A., Baldo, C., Patat, O., Bénédicte, D., Lopergolo, D., Santorelli, F.M., Haack, T.B., Dufke, A., Bertrand, M., Falb, R.J., Rieß, A., Krieg, P., Spranger, S., Bedeschi, M.F., Iascone, M., Josephi-Taylor, S., Roscioli, T., Buckley, M.F., Liebelt, J., Dagli, A.I., Aten, E., Hurst, A.C.E., Hicks, A., Suri, M., Aliu, E., Naik, S., Sidlow, R., Coursimault, J., Nicolas, G., Küpper, H., Petit, F., Ibrahim, V., Top, D., Cara, F. Di, Louie, R.J., Stolerman, E., Brunner, H.G., Vissers, L.E.L.M., Kramer, J.M., and Kleefstra, T.
- Abstract
Item does not contain fulltext, De novo variants are a leading cause of neurodevelopmental disorders (NDDs), but because every monogenic NDD is different and usually extremely rare, it remains a major challenge to understand the complete phenotype and genotype spectrum of any morbid gene. According to OMIM, heterozygous variants in KDM6B cause "neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities." Here, by examining the molecular and clinical spectrum of 85 reported individuals with mostly de novo (likely) pathogenic KDM6B variants, we demonstrate that this description is inaccurate and potentially misleading. Cognitive deficits are seen consistently in all individuals, but the overall phenotype is highly variable. Notably, coarse facies and distal skeletal anomalies, as defined by OMIM, are rare in this expanded cohort while other features are unexpectedly common (e.g., hypotonia, psychosis, etc.). Using 3D protein structure analysis and an innovative dual Drosophila gain-of-function assay, we demonstrated a disruptive effect of 11 missense/in-frame indels located in or near the enzymatic JmJC or Zn-containing domain of KDM6B. Consistent with the role of KDM6B in human cognition, we demonstrated a role for the Drosophila KDM6B ortholog in memory and behavior. Taken together, we accurately define the broad clinical spectrum of the KDM6B-related NDD, introduce an innovative functional testing paradigm for the assessment of KDM6B variants, and demonstrate a conserved role for KDM6B in cognition and behavior. Our study demonstrates the critical importance of international collaboration, sharing of clinical data, and rigorous functional analysis of genetic variants to ensure correct disease diagnosis for rare disorders.
- Published
- 2023
13. Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands.
- Author
-
Olde Keizer, R.A.C.M., Marouane, A., Kerstjens-Frederikse, W.S., Deden, A.C., Lichtenbelt, K.D., Jonckers, T., Vervoorn, M., Vreeburg, M., Henneman, L., Vries, L.S. de, Sinke, R.J., Pfundt, R.P., Stevens, S.J.C., Andriessen, P., Lingen, R.A. van, Nelen, M.R., Scheffer, H., Stemkens, D., Oosterwijk, C., Ploos van Amstel, H.K., Boode, W.P. de, Zelst-Stams, W.A.G. van, Frederix, G.W., Vissers, L.E.L.M., Olde Keizer, R.A.C.M., Marouane, A., Kerstjens-Frederikse, W.S., Deden, A.C., Lichtenbelt, K.D., Jonckers, T., Vervoorn, M., Vreeburg, M., Henneman, L., Vries, L.S. de, Sinke, R.J., Pfundt, R.P., Stevens, S.J.C., Andriessen, P., Lingen, R.A. van, Nelen, M.R., Scheffer, H., Stemkens, D., Oosterwijk, C., Ploos van Amstel, H.K., Boode, W.P. de, Zelst-Stams, W.A.G. van, Frederix, G.W., and Vissers, L.E.L.M.
- Abstract
01 juni 2023, Contains fulltext : 293809.pdf (Publisher’s version ) (Open Access), The introduction of rapid exome sequencing (rES) for critically ill neonates admitted to the neonatal intensive care unit has made it possible to impact clinical decision-making. Unbiased prospective studies to quantify the impact of rES over routine genetic testing are, however, scarce. We performed a clinical utility study to compare rES to conventional genetic diagnostic workup for critically ill neonates with suspected genetic disorders. In a multicenter prospective parallel cohort study involving five Dutch NICUs, we performed rES in parallel to routine genetic testing for 60 neonates with a suspected genetic disorder and monitored diagnostic yield and the time to diagnosis. To assess the economic impact of rES, healthcare resource use was collected for all neonates. rES detected more conclusive genetic diagnoses than routine genetic testing (20% vs. 10%, respectively), in a significantly shorter time to diagnosis (15 days (95% CI 10-20) vs. 59 days (95% CI 23-98, p < 0.001)). Moreover, rES reduced genetic diagnostic costs by 1.5% (€85 per neonate). CONCLUSION: Our findings demonstrate the clinical utility of rES for critically ill neonates based on increased diagnostic yield, shorter time to diagnosis, and net healthcare savings. Our observations warrant the widespread implementation of rES as first-tier genetic test in critically ill neonates with disorders of suspected genetic origin. WHAT IS KNOWN: • Rapid exome sequencing (rES) enables diagnosing rare genetic disorders in a fast and reliable manner, but retrospective studies with neonates admitted to the neonatal intensive care unit (NICU) indicated that genetic disorders are likely underdiagnosed as rES is not routinely used. • Scenario modeling for implementation of rES for neonates with presumed genetic disorders indicated an expected increase in costs associated with genetic testing. WHAT IS NEW: • This unique prospective national clinical utility study of rES in a NICU setting shows that rES obtained
- Published
- 2023
14. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing.
- Author
-
Denommé-Pichon, A.S., Matalonga, L., Boer, E. de, Jackson, A., Benetti, E., Banka, S., Bruel, A.L., Ciolfi, A., Clayton-Smith, J., Dallapiccola, B., Duffourd, Y., Ellwanger, K., Fallerini, C., Gilissen, C., Graessner, H., Haack, T.B., Havlovicova, M., Hoischen, A., Jean-Marçais, N., Kleefstra, T., López-Martín, E., Macek, M., Mencarelli, M.A., Moutton, S., Pfundt, R.P., Pizzi, S., Posada, M., Radio, F.C., Renieri, A., Rooryck, C., Ryba, L., Safraou, H., Schwarz, M., Tartaglia, M., Thauvin-Robinet, C., Thevenon, J., Tran Mau-Them, F., Trimouille, A., Votypka, P., Vries, B.B.A. de, Willemsen, M.H., Zurek, B., Verloes, A., Philippe, C., Vitobello, A., Vissers, L.E.L.M., Faivre, L., Denommé-Pichon, A.S., Matalonga, L., Boer, E. de, Jackson, A., Benetti, E., Banka, S., Bruel, A.L., Ciolfi, A., Clayton-Smith, J., Dallapiccola, B., Duffourd, Y., Ellwanger, K., Fallerini, C., Gilissen, C., Graessner, H., Haack, T.B., Havlovicova, M., Hoischen, A., Jean-Marçais, N., Kleefstra, T., López-Martín, E., Macek, M., Mencarelli, M.A., Moutton, S., Pfundt, R.P., Pizzi, S., Posada, M., Radio, F.C., Renieri, A., Rooryck, C., Ryba, L., Safraou, H., Schwarz, M., Tartaglia, M., Thauvin-Robinet, C., Thevenon, J., Tran Mau-Them, F., Trimouille, A., Votypka, P., Vries, B.B.A. de, Willemsen, M.H., Zurek, B., Verloes, A., Philippe, C., Vitobello, A., Vissers, L.E.L.M., and Faivre, L.
- Abstract
01 april 2023, Item does not contain fulltext, PURPOSE: Within the Solve-RD project (https://solve-rd.eu/), the European Reference Network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies aimed to investigate whether a reanalysis of exomes from unsolved cases based on ClinVar annotations could establish additional diagnoses. We present the results of the "ClinVar low-hanging fruit" reanalysis, reasons for the failure of previous analyses, and lessons learned. METHODS: Data from the first 3576 exomes (1522 probands and 2054 relatives) collected from European Reference Network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies was reanalyzed by the Solve-RD consortium by evaluating for the presence of single-nucleotide variant, and small insertions and deletions already reported as (likely) pathogenic in ClinVar. Variants were filtered according to frequency, genotype, and mode of inheritance and reinterpreted. RESULTS: We identified causal variants in 59 cases (3.9%), 50 of them also raised by other approaches and 9 leading to new diagnoses, highlighting interpretation challenges: variants in genes not known to be involved in human disease at the time of the first analysis, misleading genotypes, or variants undetected by local pipelines (variants in off-target regions, low quality filters, low allelic balance, or high frequency). CONCLUSION: The "ClinVar low-hanging fruit" analysis represents an effective, fast, and easy approach to recover causal variants from exome sequencing data, herewith contributing to the reduction of the diagnostic deadlock.
- Published
- 2023
15. PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework
- Author
-
Dingemans, A.J.M., Hinne, M., Truijen, K.M.G., Goltstein, C.M.J., Reeuwijk, J. van, Leeuw, N. de, Schuurs-Hoeijmakers, J.H.M., Pfundt, R.P., Diets, I.J., Hoed, J. den, Boer, E. de, Spek, J. van der, Bon, B.W.M. van, Ockeloen, C.W., Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Campeau, P.M., Palmer, E.E., Esch, H. van, Lyon, G.J., Alkuraya, F.S., Rauch, A., Marom, R., Baralle, D., Sluijs, P.J. van der, Santen, G.W.E., Kooy, R.F., Gerven, M.A.J. van, Vissers, L.E.L.M., Vries, L.B.A. de, Dingemans, A.J.M., Hinne, M., Truijen, K.M.G., Goltstein, C.M.J., Reeuwijk, J. van, Leeuw, N. de, Schuurs-Hoeijmakers, J.H.M., Pfundt, R.P., Diets, I.J., Hoed, J. den, Boer, E. de, Spek, J. van der, Bon, B.W.M. van, Ockeloen, C.W., Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Campeau, P.M., Palmer, E.E., Esch, H. van, Lyon, G.J., Alkuraya, F.S., Rauch, A., Marom, R., Baralle, D., Sluijs, P.J. van der, Santen, G.W.E., Kooy, R.F., Gerven, M.A.J. van, Vissers, L.E.L.M., and Vries, L.B.A. de
- Abstract
07 augustus 2023, Item does not contain fulltext, Several molecular and phenotypic algorithms exist that establish genotype–phenotype correlations, including facial recognition tools. However, no unified framework that investigates both facial data and other phenotypic data directly from individuals exists. We developed PhenoScore: an open-source, artificial intelligence-based phenomics framework, combining facial recognition technology with Human Phenotype Ontology data analysis to quantify phenotypic similarity. Here we show PhenoScore’s ability to recognize distinct phenotypic entities by establishing recognizable phenotypes for 37 of 40 investigated syndromes against clinical features observed in individuals with other neurodevelopmental disorders and show it is an improvement on existing approaches. PhenoScore provides predictions for individuals with variants of unknown significance and enables sophisticated genotype–phenotype studies by testing hypotheses on possible phenotypic (sub)groups. PhenoScore confirmed previously known phenotypic subgroups caused by variants in the same gene for SATB1, SETBP1 and DEAF1 and provides objective clinical evidence for two distinct ADNP-related phenotypes, already established functionally.
- Published
- 2023
16. On genotyping and phenotyping in pediatric neurology. The role of whole exome sequencing in a tertiary setting for pediatric neurology and the relevance of careful clinical phenotyping
- Author
-
Willemsen, M.A.A.P., Vissers, L.E.L.M., Schieving, J.H., Willemsen, M.A.A.P., Vissers, L.E.L.M., and Schieving, J.H.
- Abstract
Radboud University, 27 september 2023, Promotores : Willemsen, M.A.A.P., Vissers, L.E.L.M., Item does not contain fulltext
- Published
- 2023
17. Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis.
- Author
-
Tenney, A.P., Gioia, S.A. Di, Webb, B.D., Chan, W.M., Boer, E. de, Garnai, S.J., Barry, B.J., Ray, T., Kosicki, M., Robson, C.D., Zhang, Zhongyang, Collins, T.E., Gelber, A., Pratt, B.M., Fujiwara, Y., Varshney, A., Lek, M., Warburton, P.E., Ryzin, C. Van, Lehky, T.J., Zalewski, C., King, K.A., Brewer, C.C., Thurm, A., Snow, J., Facio, F.M., Narisu, N., Bonnycastle, L.L., Swift, A., Chines, P.S., Bell, J.L., Mohan, S., Whitman, M.C., Staffieri, S.E., Elder, J.E., Demer, J.L., Torres, A., Rachid, E., Al-Haddad, C., Boustany, R.M., Mackey, D.A., Brady, A.F., Fenollar-Cortés, M., Fradin, M., Kleefstra, T., Padberg, G.W., Raskin, S., Sato, M.T., Orkin, S.H., Parker, S.C.J., Hadlock, T.A., Vissers, L.E.L.M., Bokhoven, H. van, Jabs, E.W., Collins, F.S., Pennacchio, L.A., Manoli, I., Engle, E.C., Tenney, A.P., Gioia, S.A. Di, Webb, B.D., Chan, W.M., Boer, E. de, Garnai, S.J., Barry, B.J., Ray, T., Kosicki, M., Robson, C.D., Zhang, Zhongyang, Collins, T.E., Gelber, A., Pratt, B.M., Fujiwara, Y., Varshney, A., Lek, M., Warburton, P.E., Ryzin, C. Van, Lehky, T.J., Zalewski, C., King, K.A., Brewer, C.C., Thurm, A., Snow, J., Facio, F.M., Narisu, N., Bonnycastle, L.L., Swift, A., Chines, P.S., Bell, J.L., Mohan, S., Whitman, M.C., Staffieri, S.E., Elder, J.E., Demer, J.L., Torres, A., Rachid, E., Al-Haddad, C., Boustany, R.M., Mackey, D.A., Brady, A.F., Fenollar-Cortés, M., Fradin, M., Kleefstra, T., Padberg, G.W., Raskin, S., Sato, M.T., Orkin, S.H., Parker, S.C.J., Hadlock, T.A., Vissers, L.E.L.M., Bokhoven, H. van, Jabs, E.W., Collins, F.S., Pennacchio, L.A., Manoli, I., and Engle, E.C.
- Abstract
01 juli 2023, Item does not contain fulltext, Hereditary congenital facial paresis type 1 (HCFP1) is an autosomal dominant disorder of absent or limited facial movement that maps to chromosome 3q21-q22 and is hypothesized to result from facial branchial motor neuron (FBMN) maldevelopment. In the present study, we report that HCFP1 results from heterozygous duplications within a neuron-specific GATA2 regulatory region that includes two enhancers and one silencer, and from noncoding single-nucleotide variants (SNVs) within the silencer. Some SNVs impair binding of NR2F1 to the silencer in vitro and in vivo and attenuate in vivo enhancer reporter expression in FBMNs. Gata2 and its effector Gata3 are essential for inner-ear efferent neuron (IEE) but not FBMN development. A humanized HCFP1 mouse model extends Gata2 expression, favors the formation of IEEs over FBMNs and is rescued by conditional loss of Gata3. These findings highlight the importance of temporal gene regulation in development and of noncoding variation in rare mendelian disease.
- Published
- 2023
18. ‘Next generation cytogenetics’: ‘optical genome mapping’ verbetert detectie van cytogenetische afwijkingen bij hematologische maligniteiten.
- Author
-
Stevens-Kroef, M.J.P.L., Olde Weghuis, D.E.M., Hoischen, A., Vissers, L.E.L.M., Neveling, K., Stevens-Kroef, M.J.P.L., Olde Weghuis, D.E.M., Hoischen, A., Vissers, L.E.L.M., and Neveling, K.
- Abstract
Item does not contain fulltext
- Published
- 2023
19. Phenotype based prediction of exome sequencing outcome using machine learning for neurodevelopmental disorders
- Author
-
Dingemans, A.J.M., Hinne, M., Jansen, S, Reeuwijk, J. van, Leeuw, N. de, Pfundt, R.P., Bon, B.W.M. van, Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Gerven, M.A.J. van, Vissers, L.E.L.M., Vries, L.B.A. de, Dingemans, A.J.M., Hinne, M., Jansen, S, Reeuwijk, J. van, Leeuw, N. de, Pfundt, R.P., Bon, B.W.M. van, Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Gerven, M.A.J. van, Vissers, L.E.L.M., and Vries, L.B.A. de
- Abstract
Item does not contain fulltext, Purpose: Although the introduction of exome sequencing (ES) has led to the diagnosis of a significant portion of patients with neurodevelopmental disorders (NDDs), the diagnostic yield in actual clinical practice has remained stable at approximately 30%. We hypothesized that improving the selection of patients to test on the basis of their phenotypic presentation will increase diagnostic yield and therefore reduce unnecessary genetic testing. Methods: We tested 4 machine learning methods and developed PredWES from these: a statistical model predicting the probability of a positive ES result solely on the basis of the phenotype of the patient. Results: We first trained the tool on 1663 patients with NDDs and subsequently showed that diagnostic ES on the top 10% of patients with the highest probability of a positive ES result would provide a diagnostic yield of 56%, leading to a notable 114% increase. Inspection of our model revealed that for patients with NDDs, comorbid abnormal (lower) muscle tone and microcephaly positively correlated with a conclusive ES diagnosis, whereas autism was negatively associated with a molecular diagnosis. Conclusion: In conclusion, PredWES allows prioritizing patients with NDDs eligible for diagnostic ES on the basis of their phenotypic presentation to increase the diagnostic yield, making a more efficient use of health care resources.
- Published
- 2022
20. Genome-wide variant calling in reanalysis of exome sequencing data uncovered a pathogenic TUBB3 variant
- Author
-
Boer, E. de, Yaldiz, B., Denomme-Pichon, A.S., Matalonga, L., Laurie, S., Steyaert, Wouter, Gilissen, C.F.H.A., Kleefstra, T., Vissers, L.E.L.M., Zguro, K., Zurek, B., Boer, E. de, Yaldiz, B., Denomme-Pichon, A.S., Matalonga, L., Laurie, S., Steyaert, Wouter, Gilissen, C.F.H.A., Kleefstra, T., Vissers, L.E.L.M., Zguro, K., and Zurek, B.
- Abstract
Item does not contain fulltext
- Published
- 2022
21. Phenotype based prediction of WES outcome using machine learning
- Author
-
Dingemans, A.J.M., Hinne, M., Jansen, S, Reeuwijk, J. van, Leeuw, N. de, Pfundt, R.P., Bon, B.W.M. van, Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Gerven, M.A.J. van, Vissers, L.E.L.M., Vries, L.B.A. de, Dingemans, A.J.M., Hinne, M., Jansen, S, Reeuwijk, J. van, Leeuw, N. de, Pfundt, R.P., Bon, B.W.M. van, Vulto-van Silfhout, A.T., Kleefstra, T., Koolen, D.A., Gerven, M.A.J. van, Vissers, L.E.L.M., and Vries, L.B.A. de
- Abstract
Contains fulltext : 249711.pdf (Publisher’s version ) (Closed access)
- Published
- 2022
22. FAIR Genomes metadata schema promoting Next Generation Sequencing data reuse in Dutch healthcare and research
- Author
-
Velde, K.J. van der, Singh, G., Kaliyaperumal, Rajaram, Liao, X., Ridder, Sander de, Rebers, Susanne, Weiss, M.M., Reeuwijk, J. van, Vissers, L.E.L.M., Hoen, P.A.C. 't, Gijn, Marielle E. van, Swertz, M., Velde, K.J. van der, Singh, G., Kaliyaperumal, Rajaram, Liao, X., Ridder, Sander de, Rebers, Susanne, Weiss, M.M., Reeuwijk, J. van, Vissers, L.E.L.M., Hoen, P.A.C. 't, Gijn, Marielle E. van, and Swertz, M.
- Abstract
Item does not contain fulltext
- Published
- 2022
23. Congenital anomalies and genetic disorders in neonates and infants: a single-center observational cohort study
- Author
-
Marouane, A., Oude Keizer, R.A.C.M., Frederix, G.W., Vissers, L.E.L.M., Boode, W.P. de, Zelst-Stams, W.A.G. van, Marouane, A., Oude Keizer, R.A.C.M., Frederix, G.W., Vissers, L.E.L.M., Boode, W.P. de, and Zelst-Stams, W.A.G. van
- Abstract
Item does not contain fulltext, Neonates with genetic disorders or congenital anomalies (CA) contribute considerably to morbidity and mortality in neonatal intensive care units (NICUs). The objective of this study is to study the prevalence of genetic disorders in an academic level IV NICU. We retrospective collected and analyzed both clinical and genetic data of all 1444 infants admitted to the NICU of the Radboudumc (October 2013 to October 2015). Data were collected until infants reached at least 2 years of age. A total of 13% (194/1444) of the patients were genetically tested, and 32% (461/1444) had a CA. A total of 37% (72/194) had a laboratory-confirmed genetic diagnosis. In 53%, the diagnosis was made post-neonatally (median age = 209 days) using assays including exome sequencing. Exactly 63% (291/461) of the patients with CA, however, never received genetic testing, despite being clinically similar those who did.Conclusions: Genetic disorders were suspected in 13% of the cohort, but only confirmed in 5%. Most received their genetic diagnosis in the post-neonatal period. Extrapolation of the diagnostic yield suggests that up to 6% of our cohort may have remained genetically undiagnosed. Our data show the need to improve genetic care in the NICU for more inclusive, earlier, and faster genetic diagnosis to enable tailored management. What is Known: • Genetic disorders are suspected in many neonates but only genetically confirmed in a minority. • The presence of a genetic disorder can be easily missed and will often lead to a diagnostic odyssey requiring extensive evaluations, both clinically and genetically. What is New: • Different aspects of the clinical features and uptake of genetic test in a NICU cohort. • The need to improve genetic care in the NICU for more inclusive, earlier, and faster genetic diagnosis to enable tailored management.
- Published
- 2022
24. A de novo paradigm for male infertility
- Author
-
Oud, M.S., Smits, R.M., Smith, H.E., Mastrorosa, F.K., Holt, G.S., Houston, B.J., Vries, P.F. de, Alobaidi, B.K.S., Batty, L.E., Ismail, H., Greenwood, J., Sheth, H., Mikulasova, A., Astuti, G.D.N, Gilissen, C., McEleny, K., Turner, H., Coxhead, J., Cockell, S., Braat, D.D.M., Fleischer, K., D'Hauwers, K.W.M., Schaafsma, E., Nagirnaja, L., Conrad, D.F., Friedrich, C., Kliesch, S., Aston, K.I., Riera-Escamilla, A., Krausz, C., Gonzaga-Jauregui, C., Santibanez-Koref, M., Elliott, D.J., Vissers, L.E.L.M., Tüttelmann, F., O'Bryan, M.K., Ramos, L., Xavier, M.J., Heijden, G.W. van der, Veltman, J.A., Oud, M.S., Smits, R.M., Smith, H.E., Mastrorosa, F.K., Holt, G.S., Houston, B.J., Vries, P.F. de, Alobaidi, B.K.S., Batty, L.E., Ismail, H., Greenwood, J., Sheth, H., Mikulasova, A., Astuti, G.D.N, Gilissen, C., McEleny, K., Turner, H., Coxhead, J., Cockell, S., Braat, D.D.M., Fleischer, K., D'Hauwers, K.W.M., Schaafsma, E., Nagirnaja, L., Conrad, D.F., Friedrich, C., Kliesch, S., Aston, K.I., Riera-Escamilla, A., Krausz, C., Gonzaga-Jauregui, C., Santibanez-Koref, M., Elliott, D.J., Vissers, L.E.L.M., Tüttelmann, F., O'Bryan, M.K., Ramos, L., Xavier, M.J., Heijden, G.W. van der, and Veltman, J.A.
- Abstract
Item does not contain fulltext, De novo mutations are known to play a prominent role in sporadic disorders with reduced fitness. We hypothesize that de novo mutations play an important role in severe male infertility and explain a portion of the genetic causes of this understudied disorder. To test this hypothesis, we utilize trio-based exome sequencing in a cohort of 185 infertile males and their unaffected parents. Following a systematic analysis, 29 of 145 rare (MAF < 0.1%) protein-altering de novo mutations are classified as possibly causative of the male infertility phenotype. We observed a significant enrichment of loss-of-function de novo mutations in loss-of-function-intolerant genes (p-value = 1.00 × 10(-5)) in infertile men compared to controls. Additionally, we detected a significant increase in predicted pathogenic de novo missense mutations affecting missense-intolerant genes (p-value = 5.01 × 10(-4)) in contrast to predicted benign de novo mutations. One gene we identify, RBM5, is an essential regulator of male germ cell pre-mRNA splicing and has been previously implicated in male infertility in mice. In a follow-up study, 6 rare pathogenic missense mutations affecting this gene are observed in a cohort of 2,506 infertile patients, whilst we find no such mutations in a cohort of 5,784 fertile men (p-value = 0.03). Our results provide evidence for the role of de novo mutations in severe male infertility and point to new candidate genes affecting fertility.
- Published
- 2022
25. Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals
- Author
-
Schoot, V. van der, Haer-Wigman, L., Feenstra, I., Tammer, Femke, Oerlemans, A.J.M., Koolwijk, M.P. van, Agt, F. van, Arens, Y., Brunner, H.G., Vissers, L.E.L.M., Yntema, H.G., Schoot, V. van der, Haer-Wigman, L., Feenstra, I., Tammer, Femke, Oerlemans, A.J.M., Koolwijk, M.P. van, Agt, F. van, Arens, Y., Brunner, H.G., Vissers, L.E.L.M., and Yntema, H.G.
- Abstract
Item does not contain fulltext, Unsolicited findings (UFs) are uncovered unintentionally and predispose to a disease unrelated to the clinical question. The frequency and nature of UFs uncovered in clinical practice remain largely unexplored. We here evaluated UFs identified during a 5-year period in which 16,482 index patients received clinical whole-exome sequencing (WES). UFs were identified in 0.58% (95/16,482) of index patients, indicating that the overall frequency of UFs in clinical WES is low. Fewer UFs were identified using restricted disease-gene panels (0.03%) than when using whole-exome/Mendeliome analysis (1.03%). The UF was disclosed to 86 of 95 individuals, for reasons of medical actionability. Only 61% of these UFs reside in a gene that is listed on the "ACMG59"-list, representing a list of 59 genes for which the American College of Medical Genetics recommends UF disclosure. The remaining 39% were grouped into four categories: disorders similar to "ACMG59"-listed disorders (25%); disorders for which disease manifestation could be influenced (7%); UFs providing reproductive options (2%); and UFs with pharmacogenetic implications (5%). Hence, our experience shows that UFs predisposing to medically actionable disorders affect a broader range of genes than listed on the "ACMG59", advocating that a pre-defined gene list is too restrictive, and that UFs may require ad hoc evaluation of medical actionability. While both the identification and disclosure of UFs depend on local policy, our lessons learned provide general essential insight into the nature and odds of UFs in clinical exome sequencing.
- Published
- 2022
26. Medical costs of children admitted to the neonatal intensive care unit: The role and possible economic impact of WES in early diagnosis
- Author
-
Olde Keizer, R.A.C.M., Marouane, A., Deden, A.C., Zelst-Stams, W.A.G. van, Boode, W.P. de, Keusters, Willem R., Frederix, G.W., Vissers, L.E.L.M., Olde Keizer, R.A.C.M., Marouane, A., Deden, A.C., Zelst-Stams, W.A.G. van, Boode, W.P. de, Keusters, Willem R., Frederix, G.W., and Vissers, L.E.L.M.
- Abstract
Item does not contain fulltext
- Published
- 2022
27. Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON
- Author
-
Dingemans, A.J.M., Truijen, K.M.G., Kim, J.H., Alaçam, Z., Faivre, L., Collins, K.M., Gerkes, E.H., Haelst, M. van, Laar, I. van de, Lindstrom, K., Nizon, M., Pauling, J., Heropolitańska-Pliszka, E., Plomp, A.S., Racine, C., Sachdev, R., Sinnema, M., Skranes, J., Veenstra-Knol, Hermine E., Verberne, E.A., Vulto-van Silfhout, A.T., Wilsterman, M.E., Ahn, E.E., Vries, B.B.A. de, Vissers, L.E.L.M., Dingemans, A.J.M., Truijen, K.M.G., Kim, J.H., Alaçam, Z., Faivre, L., Collins, K.M., Gerkes, E.H., Haelst, M. van, Laar, I. van de, Lindstrom, K., Nizon, M., Pauling, J., Heropolitańska-Pliszka, E., Plomp, A.S., Racine, C., Sachdev, R., Sinnema, M., Skranes, J., Veenstra-Knol, Hermine E., Verberne, E.A., Vulto-van Silfhout, A.T., Wilsterman, M.E., Ahn, E.E., Vries, B.B.A. de, and Vissers, L.E.L.M.
- Abstract
Contains fulltext : 248367.pdf (Publisher’s version ) (Closed access), Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.
- Published
- 2022
28. Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome
- Author
-
Spek, J. van der, Hoed, J. den, Snijders Blok, L., Dingemans, A.J., Schijven, Dick, Nellaker, C., Venselaar, H., Astuti, G.D.N, Brunner, H.G., Gilissen, C., Vries, B.B.A. de, Willemsen, M.H., Francks, C., Peart-Vissers, L.E.L.M., Fisher, S.E., Kleefstra, T., Spek, J. van der, Hoed, J. den, Snijders Blok, L., Dingemans, A.J., Schijven, Dick, Nellaker, C., Venselaar, H., Astuti, G.D.N, Brunner, H.G., Gilissen, C., Vries, B.B.A. de, Willemsen, M.H., Francks, C., Peart-Vissers, L.E.L.M., Fisher, S.E., and Kleefstra, T.
- Abstract
Contains fulltext : 251115.pdf (Publisher’s version ) (Closed access)
- Published
- 2022
29. Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications
- Author
-
Schobers, G.M.G., Schieving, J.H., Yntema, H.G., Pennings, Maartje, Pfundt, R.P., Derks, R.C., Hofste, Tom, Wijs, I.J. de, Wieskamp, N.A., Heuvel, Simone van den, Corominas-Galbany, J., Gilissen, C.F.H.A., Nelen, M.R., Brunner, H.G., Kleefstra, T., Kamsteeg, E.J., Willemsen, M.A.A.P., Vissers, L.E.L.M., Schobers, G.M.G., Schieving, J.H., Yntema, H.G., Pennings, Maartje, Pfundt, R.P., Derks, R.C., Hofste, Tom, Wijs, I.J. de, Wieskamp, N.A., Heuvel, Simone van den, Corominas-Galbany, J., Gilissen, C.F.H.A., Nelen, M.R., Brunner, H.G., Kleefstra, T., Kamsteeg, E.J., Willemsen, M.A.A.P., and Vissers, L.E.L.M.
- Abstract
Item does not contain fulltext
- Published
- 2022
30. Disentangling the molecular landscape of genetic variation of neurodevelopmental and speech disorders
- Author
-
Fisher, S.E., Vissers, L.E.L.M., Hoed, J. den, Fisher, S.E., Vissers, L.E.L.M., and Hoed, J. den
- Abstract
Radboud University, 14 november 2022, Promotores : Fisher, S.E., Vissers, L.E.L.M., Contains fulltext : 283910.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
31. De novo mutations in children born after medical assisted reproduction
- Author
-
Smits, R.M., Xavier, M.J., Oud, M.S., Astuti, G.D.N, Meijerink, A.M., Vries, P.F. de, Holt, G.S., Alobaidi, B.K.S., Batty, L.E., Khazeeva, G., Sablauskas, K., Vissers, L.E.L.M., Gilissen, C., Fleischer, K., Braat, D.D.M., Ramos, L., Veltman, J.A., Smits, R.M., Xavier, M.J., Oud, M.S., Astuti, G.D.N, Meijerink, A.M., Vries, P.F. de, Holt, G.S., Alobaidi, B.K.S., Batty, L.E., Khazeeva, G., Sablauskas, K., Vissers, L.E.L.M., Gilissen, C., Fleischer, K., Braat, D.D.M., Ramos, L., and Veltman, J.A.
- Abstract
Contains fulltext : 251982.pdf (Publisher’s version ) (Open Access), STUDY QUESTION: Are there more de novo mutations (DNMs) present in the genomes of children born through medical assisted reproduction (MAR) compared to spontaneously conceived children? SUMMARY ANSWER: In this pilot study, no statistically significant difference was observed in the number of DNMs observed in the genomes of MAR children versus spontaneously conceived children. WHAT IS KNOWN ALREADY: DNMs are known to play a major role in sporadic disorders with reduced fitness such as severe developmental disorders, including intellectual disability and epilepsy. Advanced paternal age is known to place offspring at increased disease risk, amongst others by increasing the number of DNMs in their genome. There are very few studies reporting on the effect of MAR on the number of DNMs in the offspring, especially when male infertility is known to be affecting the potential fathers. With delayed parenthood an ongoing epidemiological trend in the 21st century, there are more children born from fathers of advanced age and more children born through MAR every day. STUDY DESIGN, SIZE, DURATION: This observational pilot study was conducted from January 2015 to March 2019 in the tertiary care centre at Radboud University Medical Center. We included a total of 53 children and their respective parents, forming 49 trios (mother, father and child) and two quartets (mother, father and two siblings). One group of children was born after spontaneous conception (n = 18); a second group of children born after IVF (n = 17) and a third group of children born after ICSI combined with testicular sperm extraction (ICSI-TESE) (n = 18). In this pilot study, we also subdivided each group by paternal age, resulting in a subgroup of children born to younger fathers (<35 years of age at conception) and older fathers (>45 years of age at conception). PARTICIPANTS/MATERIALS, SETTING, METHODS: Whole-genome sequencing (WGS) was performed on all parent-offspring trios to identify DNMs. For 34 of 53 tri
- Published
- 2022
32. DeNovoCNN: A deep learning approach to de novo variant calling in next generation sequencing data
- Author
-
Khazeeva, G., Sablauskas, K., Sanden, P.G.H. van der, Steyaert, W.A.R., Kwint, M.P., Rots, D., Hinne, M., Gerven, M.A.J. van, Yntema, H.G., Vissers, L.E.L.M., Gilissen, C.F.H.A., Khazeeva, G., Sablauskas, K., Sanden, P.G.H. van der, Steyaert, W.A.R., Kwint, M.P., Rots, D., Hinne, M., Gerven, M.A.J. van, Yntema, H.G., Vissers, L.E.L.M., and Gilissen, C.F.H.A.
- Abstract
Contains fulltext : 251286.pdf (Publisher’s version ) (Open Access), De novo mutations (DNMs) are an important cause of genetic disorders. The accurate identification of DNMs from sequencing data is therefore fundamental to rare disease research and diagnostics. Unfortunately, identifying reliable DNMs remains a major challenge due to sequence errors, uneven coverage, and mapping artifacts. Here, we developed a deep convolutional neural network (CNN) DNM caller (DeNovoCNN), that encodes the alignment of sequence reads for a trio as 160×164 resolution images. DeNovoCNN was trained on DNMs of 5616 whole exome sequencing (WES) trios achieving total 96.74% recall and 96.55% precision on the test dataset. We find that DeNovoCNN has increased recall/sensitivity and precision compared to existing DNM calling approaches (GATK, DeNovoGear, DeepTrio, Samtools) based on the Genome in a Bottle reference dataset and independent WES and WGS trios. Validations of DNMs based on Sanger and PacBio HiFi sequencing confirm that DeNovoCNN outperforms existing methods. Most importantly, our results suggest that DeNovoCNN is likely robust against different exome sequencing and analyses approaches, thereby allowing the application on other datasets. DeNovoCNN is freely available as a Docker container and can be run on existing alignment (BAM/CRAM) and variant calling (VCF) files from WES and WGS without a need for variant recalling.
- Published
- 2022
33. The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8
- Author
-
Dingemans, A.J.M., Truijen, Kim M.G., Ven, Sam van de, Bernier, R., Bongers, E.M.H.F., Bouman, Arjan, Kleefstra, T., Vissers, L.E.L.M., Vries, B.B.A. de, Dingemans, A.J.M., Truijen, Kim M.G., Ven, Sam van de, Bernier, R., Bongers, E.M.H.F., Bouman, Arjan, Kleefstra, T., Vissers, L.E.L.M., and Vries, B.B.A. de
- Abstract
Contains fulltext : 282761.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
34. Diagnostic analysis of the highly complex OPN1LW/OPN1MW gene cluster using long-read sequencing and MLPA
- Author
-
Haer-Wigman, L., Ouden, A.P.M. den, Genderen, Maria m. van, Kroes, H.Y., Verheij, J., Smailhodzic, Dzenita, Blom, Jan, Derks, R.C., Yntema, H.G., Nelen, M.R., Vissers, L.E.L.M., Lugtenberg, D., Neveling, K., Haer-Wigman, L., Ouden, A.P.M. den, Genderen, Maria m. van, Kroes, H.Y., Verheij, J., Smailhodzic, Dzenita, Blom, Jan, Derks, R.C., Yntema, H.G., Nelen, M.R., Vissers, L.E.L.M., Lugtenberg, D., and Neveling, K.
- Abstract
Contains fulltext : 285305.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
35. Missense variants in ANKRD11 cause KBG syndrome by impairment of stability or transcriptional activity of the encoded protein
- Author
-
Boer, E. de, Ockeloen, C.W., Kampen, R.A., Hampstead, J.E., Dingemans, A.J.M., Rots, D., Pfundt, R.P., Reeuwijk, J. van, Gilissen, C.F.H.A., Vissers, L.E.L.M., Wong, M., Fisher, S.E., Kleefstra, T., Boer, E. de, Ockeloen, C.W., Kampen, R.A., Hampstead, J.E., Dingemans, A.J.M., Rots, D., Pfundt, R.P., Reeuwijk, J. van, Gilissen, C.F.H.A., Vissers, L.E.L.M., Wong, M., Fisher, S.E., and Kleefstra, T.
- Abstract
Contains fulltext : 284428.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
36. How to proceed after 'negative' exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques
- Author
-
Wortmann, S.B., Oud, M.M., Alders, M., Coene, K.L.M., Crabben, S.N. van der, Feichtinger, R.G., Garanto, A., Hoischen, A., Langeveld, M., Lefeber, D.J., Mayr, J.A., Ockeloen, C.W., Prokisch, H., Rodenburg, R.J., Waterham, H.R., Wevers, R.A., Warrenburg, B.P.C. van de, Willemsen, M.A.A.P., Wolf, N.I., Vissers, L.E.L.M., Karnebeek, C.D. van, Wortmann, S.B., Oud, M.M., Alders, M., Coene, K.L.M., Crabben, S.N. van der, Feichtinger, R.G., Garanto, A., Hoischen, A., Langeveld, M., Lefeber, D.J., Mayr, J.A., Ockeloen, C.W., Prokisch, H., Rodenburg, R.J., Waterham, H.R., Wevers, R.A., Warrenburg, B.P.C. van de, Willemsen, M.A.A.P., Wolf, N.I., Vissers, L.E.L.M., and Karnebeek, C.D. van
- Abstract
Contains fulltext : 282561.pdf (Publisher’s version ) (Open Access), Exome sequencing (ES) in the clinical setting of inborn metabolic diseases (IMDs) has created tremendous improvement in achieving an accurate and timely molecular diagnosis for a greater number of patients, but it still leaves the majority of patients without a diagnosis. In parallel, (personalized) treatment strategies are increasingly available, but this requires the availability of a molecular diagnosis. IMDs comprise an expanding field with the ongoing identification of novel disease genes and the recognition of multiple inheritance patterns, mosaicism, variable penetrance, and expressivity for known disease genes. The analysis of trio ES is preferred over singleton ES as information on the allelic origin (paternal, maternal, "de novo") reduces the number of variants that require interpretation. All ES data and interpretation strategies should be exploited including CNV and mitochondrial DNA analysis. The constant advancements in available techniques and knowledge necessitate the close exchange of clinicians and molecular geneticists about genotypes and phenotypes, as well as knowledge of the challenges and pitfalls of ES to initiate proper further diagnostic steps. Functional analyses (transcriptomics, proteomics, and metabolomics) can be applied to characterize and validate the impact of identified variants, or to guide the genomic search for a diagnosis in unsolved cases. Future diagnostic techniques (genome sequencing [GS], optical genome mapping, long-read sequencing, and epigenetic profiling) will further enhance the diagnostic yield. We provide an overview of the challenges and limitations inherent to ES followed by an outline of solutions and a clinical checklist, focused on establishing a diagnosis to eventually achieve (personalized) treatment.
- Published
- 2022
37. Episignature Mapping of TRIP12 Provides Functional Insight into Clark-Baraitser Syndrome
- Author
-
Laan, L. van der, Rooney, K., Alders, M., Relator, Raissa, McConkey, H., Kerkhof, J., Vissers, L.E.L.M., Haelst, M. van, Henneman, Peter, Laan, L. van der, Rooney, K., Alders, M., Relator, Raissa, McConkey, H., Kerkhof, J., Vissers, L.E.L.M., Haelst, M. van, and Henneman, Peter
- Abstract
Item does not contain fulltext
- Published
- 2022
38. Congenital anomalies and genetic disorders in neonates and infants: a single-center observational cohort study
- Author
-
HEE, Child Health, JC onderzoeksprogramma Methodologie, Marouane, A., Olde Keizer, R. A.C.M., Frederix, G. W.J., Vissers, L.E.L.M., Boode, W. P.de, Zelst-Stams, W. A.G.van, HEE, Child Health, JC onderzoeksprogramma Methodologie, Marouane, A., Olde Keizer, R. A.C.M., Frederix, G. W.J., Vissers, L.E.L.M., Boode, W. P.de, and Zelst-Stams, W. A.G.van
- Published
- 2022
39. A de novo paradigm for male infertility
- Author
-
Oud M.S., Smits R.M., Smith H.E., Mastrorosa F.K., Holt G.S., Houston B.J., de Vries P.F., Alobaidi B.K.S., Batty L.E., Ismail H., Greenwood J., Sheth H., Mikulasova A., Astuti G.D.N., Gilissen C., McEleny K., Turner H., Coxhead J., Cockell S., Braat D.D.M., Fleischer K., D’Hauwers K.W.M., Schaafsma E., Carrell D.T., Hotaling J.M., Jenkins T.G., McLachlan R., Schlegel P.N., Eisenberg M.L., Sandlow J.I., Jungheim E.S., Omurtag K.R., Lopes A.M., Seixas S., Carvalho F., Fernandes S., Barros A., Gonçalves J., Caetano I., Pinto G., Correia S., Laan M., Punab M., Meyts E.R.-D., Jørgensen N., Almstrup K., Krausz C.G., Jarvi K.A., Nagirnaja L., Conrad D.F., Friedrich C., Kliesch S., Aston K.I., Riera-Escamilla A., Krausz C., Gonzaga-Jauregui C., Santibanez-Koref M., Elliott D.J., Vissers L.E.L.M., Tüttelmann F., O’Bryan M.K., Ramos L., Xavier M.J., van der Heijden G.W., Veltman J.A., and Genetics of Male Infertility Initiative (GEMINI) consortium
- Subjects
Adult ,Male ,phenotype ,Mutation, Missense ,Gene Expression ,Cell Cycle Proteins ,Whole Exome Sequencing ,loss of function mutation ,cell cycle protein ,gene expression profiling ,Humans ,genetics ,Exome ,Genetic Predisposition to Disease ,human ,tumor suppressor protein ,oligospermia ,Azoospermia ,missense mutation ,Tumor Suppressor Proteins ,RNA-Binding Proteins ,case control study ,RNA binding protein ,DNA binding protein ,RBM5 protein, human ,DNA-Binding Proteins ,Case-Control Studies ,RNA ,pathology ,mutation ,infertility ,genetic predisposition - Abstract
De novo mutations are known to play a prominent role in sporadic disorders with reduced fitness. We hypothesize that de novo mutations play an important role in severe male infertility and explain a portion of the genetic causes of this understudied disorder. To test this hypothesis, we utilize trio-based exome sequencing in a cohort of 185 infertile males and their unaffected parents. Following a systematic analysis, 29 of 145 rare (MAF < 0.1%) protein-altering de novo mutations are classified as possibly causative of the male infertility phenotype. We observed a significant enrichment of loss-of-function de novo mutations in loss-of-function-intolerant genes (p-value = 1.00 × 10-5) in infertile men compared to controls. Additionally, we detected a significant increase in predicted pathogenic de novo missense mutations affecting missense-intolerant genes (p-value = 5.01 × 10-4) in contrast to predicted benign de novo mutations. One gene we identify, RBM5, is an essential regulator of male germ cell pre-mRNA splicing and has been previously implicated in male infertility in mice. In a follow-up study, 6 rare pathogenic missense mutations affecting this gene are observed in a cohort of 2,506 infertile patients, whilst we find no such mutations in a cohort of 5,784 fertile men (p-value = 0.03). Our results provide evidence for the role of de novo mutations in severe male infertility and point to new candidate genes affecting fertility. © 2022, The Author(s).
- Published
- 2022
- Full Text
- View/download PDF
40. Characterization of the GABRB2-Associated Neurodevelopmental Disorders
- Author
-
Achkar, C.M. El, Harrer, M., Smith, L., Kelly, M., Iqbal, S., Maljevic, S., Niturad, C.E., Vissers, L.E.L.M., Poduri, A., Yang, E., Lal, D., Lerche, H., Møller, R.S., Olson, H.E., Achkar, C.M. El, Harrer, M., Smith, L., Kelly, M., Iqbal, S., Maljevic, S., Niturad, C.E., Vissers, L.E.L.M., Poduri, A., Yang, E., Lal, D., Lerche, H., Møller, R.S., and Olson, H.E.
- Abstract
Item does not contain fulltext, OBJECTIVE: We aimed to characterize the phenotypic spectrum and functional consequences associated with variants in the gene GABRB2, coding for the γ-aminobutyric acid type A (GABA(A) ) receptor subunit β2. METHODS: We recruited and systematically evaluated 25 individuals with variants in GABRB2, 17 of whom are newly described and 8 previously reported with additional clinical data. Functional analysis was performed using a Xenopus laevis oocyte model system. RESULTS: Our cohort of 25 individuals from 22 families with variants in GABRB2 demonstrated a range of epilepsy phenotypes from genetic generalized epilepsy to developmental and epileptic encephalopathy. Fifty-eight percent of individuals had pharmacoresistant epilepsy; response to medications targeting the GABAergic pathway was inconsistent. Developmental disability (present in 84%) ranged from mild intellectual disability to severe global disability; movement disorders (present in 44%) included choreoathetosis, dystonia, and ataxia. Disease-associated variants cluster in the extracellular N-terminus and transmembrane domains 1-3, with more severe phenotypes seen in association with variants in transmembrane domains 1 and 2 and the allosteric binding site between transmembrane domains 2 and 3. Functional analysis of 4 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents. INTERPRETATION: GABRB2-related epilepsy ranges broadly in severity from genetic generalized epilepsy to developmental and epileptic encephalopathies. Developmental disability and movement disorder are key features. The phenotypic spectrum is comparable to other GABA(A) receptor-encoding genes. Phenotypic severity varies by protein domain. Experimental evidence supports loss of GABAergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders. ANN NEUROL 2021;89:573-586.
- Published
- 2021
41. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders
- Author
-
Gillentine, M.A., Wang, T., Hoekzema, K., Rosenfeld, J., Liu, P, Guo, H, Kim, C.N., Vries, B.B. de, Vissers, L.E.L.M., Nordenskjold, M., Kvarnung, M., Lindstrand, A., Nordgren, A., Gecz, J., Iascone, M., Cereda, A., Scatigno, A., Maitz, S., Zanni, G., Bertini, E., Zweier, C., Schuhmann, S., Wiesener, A., Pepper, M., Panjwani, H., Torti, E., Abid, F., Anselm, I., Srivastava, S., Atwal, P., Bacino, C.A., Bhat, G., Cobian, K., Bird, L.M., Friedman, J., Wright, M.S., Callewaert, B., Petit, F., Mathieu, S., Afenjar, A., Christensen, C.K., White, K.M., Elpeleg, O., Berger, I., Espineli, E.J., Fagerberg, C., Brasch-Andersen, C., Hansen, L.K., Feyma, T., Hughes, S., Thiffault, I., Sullivan, B., Yan, S., Keller, K., Keren, B., Mignot, C., Kooy, F., Meuwissen, M., Basinger, A., Kukolich, M., Philips, M., Ortega, L., Drummond-Borg, M., Lauridsen, M., Sorensen, K., Lehman, A., Lopez-Rangel, E., Levy, P., Lessel, D., Lotze, T., Madan-Khetarpal, S., Sebastian, J., Vento, J., Vats, D., Benman, L.M., McKee, S., Mirzaa, G.M., Muss, C., Pappas, J., Peeters, H, Romano, C, Elia, M., Galesi, O., Simon, M.E., Gassen, K.L.I. van, Simpson, K., Stratton, R., Syed, S., Thevenon, J., Palafoll, I.V., Vitobello, A., Bournez, M., Faivre, L., Xia, K., Earl, R.K., Nowakowski, T., Bernier, R.A., Eichler, E.E., Gillentine, M.A., Wang, T., Hoekzema, K., Rosenfeld, J., Liu, P, Guo, H, Kim, C.N., Vries, B.B. de, Vissers, L.E.L.M., Nordenskjold, M., Kvarnung, M., Lindstrand, A., Nordgren, A., Gecz, J., Iascone, M., Cereda, A., Scatigno, A., Maitz, S., Zanni, G., Bertini, E., Zweier, C., Schuhmann, S., Wiesener, A., Pepper, M., Panjwani, H., Torti, E., Abid, F., Anselm, I., Srivastava, S., Atwal, P., Bacino, C.A., Bhat, G., Cobian, K., Bird, L.M., Friedman, J., Wright, M.S., Callewaert, B., Petit, F., Mathieu, S., Afenjar, A., Christensen, C.K., White, K.M., Elpeleg, O., Berger, I., Espineli, E.J., Fagerberg, C., Brasch-Andersen, C., Hansen, L.K., Feyma, T., Hughes, S., Thiffault, I., Sullivan, B., Yan, S., Keller, K., Keren, B., Mignot, C., Kooy, F., Meuwissen, M., Basinger, A., Kukolich, M., Philips, M., Ortega, L., Drummond-Borg, M., Lauridsen, M., Sorensen, K., Lehman, A., Lopez-Rangel, E., Levy, P., Lessel, D., Lotze, T., Madan-Khetarpal, S., Sebastian, J., Vento, J., Vats, D., Benman, L.M., McKee, S., Mirzaa, G.M., Muss, C., Pappas, J., Peeters, H, Romano, C, Elia, M., Galesi, O., Simon, M.E., Gassen, K.L.I. van, Simpson, K., Stratton, R., Syed, S., Thevenon, J., Palafoll, I.V., Vitobello, A., Bournez, M., Faivre, L., Xia, K., Earl, R.K., Nowakowski, T., Bernier, R.A., and Eichler, E.E.
- Abstract
Contains fulltext : 245103.pdf (Publisher’s version ) (Open Access), BACKGROUND: With the increasing number of genomic sequencing studies, hundreds of genes have been implicated in neurodevelopmental disorders (NDDs). The rate of gene discovery far outpaces our understanding of genotype-phenotype correlations, with clinical characterization remaining a bottleneck for understanding NDDs. Most disease-associated Mendelian genes are members of gene families, and we hypothesize that those with related molecular function share clinical presentations. METHODS: We tested our hypothesis by considering gene families that have multiple members with an enrichment of de novo variants among NDDs, as determined by previous meta-analyses. One of these gene families is the heterogeneous nuclear ribonucleoproteins (hnRNPs), which has 33 members, five of which have been recently identified as NDD genes (HNRNPK, HNRNPU, HNRNPH1, HNRNPH2, and HNRNPR) and two of which have significant enrichment in our previous meta-analysis of probands with NDDs (HNRNPU and SYNCRIP). Utilizing protein homology, mutation analyses, gene expression analyses, and phenotypic characterization, we provide evidence for variation in 12 HNRNP genes as candidates for NDDs. Seven are potentially novel while the remaining genes in the family likely do not significantly contribute to NDD risk. RESULTS: We report 119 new NDD cases (64 de novo variants) through sequencing and international collaborations and combined with published clinical case reports. We consider 235 cases with gene-disruptive single-nucleotide variants or indels and 15 cases with small copy number variants. Three hnRNP-encoding genes reach nominal or exome-wide significance for de novo variant enrichment, while nine are candidates for pathogenic mutations. Comparison of HNRNP gene expression shows a pattern consistent with a role in cerebral cortical development with enriched expression among radial glial progenitors. Clinical assessment of probands (n = 188-221) expands the phenotypes associated with HNRNP rare va
- Published
- 2021
42. Genetic convergence of developmental and epileptic encephalopathies and intellectual disability
- Author
-
Carvill, G.L., Jansen, S, Lacroix, A., Zemel, M., Mehaffey, M., Vries, P.F. de, Brunner, H.G., Scheffer, I.E., Vries, B.B. de, Vissers, L.E.L.M., Mefford, H.C., Carvill, G.L., Jansen, S, Lacroix, A., Zemel, M., Mehaffey, M., Vries, P.F. de, Brunner, H.G., Scheffer, I.E., Vries, B.B. de, Vissers, L.E.L.M., and Mefford, H.C.
- Abstract
Item does not contain fulltext, AIM: To determine whether genes that cause developmental and epileptic encephalopathies (DEEs) are more commonly implicated in intellectual disability with epilepsy as a comorbid feature than in intellectual disability only. METHOD: We performed targeted resequencing of 18 genes commonly implicated in DEEs in a cohort of 830 patients with intellectual disability (59% male) and 393 patients with DEEs (52% male). RESULTS: We observed a significant enrichment of pathogenic/likely pathogenic variants in patients with epilepsy and intellectual disability (16 out of 159 in seven genes) compared with intellectual disability only (2 out of 671) (p<1.86×10(-10) , odds ratio 37.22, 95% confidence interval 8.60-337.0). INTERPRETATION: We identified seven genes that are more likely to cause epilepsy and intellectual disability than intellectual disability only. Conversely, two genes, GRIN2B and SCN2A, can be implicated in intellectual disability without epilepsy; in these instances intellectual disability is not a secondary consequence of ongoing seizures but rather a primary cause. What this paper adds A subset of genes are more commonly implicated in epilepsy than other neurodevelopmental disorders. GRIN2B and SCN2A are implicated in intellectual disability and epilepsy independently.
- Published
- 2021
43. Long-read technologies identify a hidden inverted duplication in a family with choroideremia
- Author
-
Fadaie, Z., Neveling, K., Mantere, T., Derks, R.C., Haer-Wigman, L., Ouden, A. Den, Kwint, M.P., O’Gorman, L., Valkenburg, D., Hoyng, C.B., Gilissen, C., Vissers, L.E.L.M., Nelen, M.R., Cremers, F.P.M., Hoischen, A., Roosing, S., Fadaie, Z., Neveling, K., Mantere, T., Derks, R.C., Haer-Wigman, L., Ouden, A. Den, Kwint, M.P., O’Gorman, L., Valkenburg, D., Hoyng, C.B., Gilissen, C., Vissers, L.E.L.M., Nelen, M.R., Cremers, F.P.M., Hoischen, A., and Roosing, S.
- Abstract
Contains fulltext : 244033.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
44. Cell-based assay for ciliopathy patients to improve accurate diagnosis using ALPACA
- Author
-
Beek, R. van, Bongers, E.M.H.F., Lugtenberg, D., Klaren, P.H.M., Vissers, L.E.L.M., Roepman, R., Oud, M.M., Beek, R. van, Bongers, E.M.H.F., Lugtenberg, D., Klaren, P.H.M., Vissers, L.E.L.M., Roepman, R., and Oud, M.M.
- Abstract
Contains fulltext : 241056.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
45. SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype
- Author
-
Motta, M., Fasano, Giulia, Gredy, Sina, Brinkmann, Julia, Bonnard, Adeline Alice, Simsek-Kiper, P.O., Boer, E. de, Vissers, L.E.L.M., Zenker, M., Tartaglia, M., Motta, M., Fasano, Giulia, Gredy, Sina, Brinkmann, Julia, Bonnard, Adeline Alice, Simsek-Kiper, P.O., Boer, E. de, Vissers, L.E.L.M., Zenker, M., and Tartaglia, M.
- Abstract
Item does not contain fulltext
- Published
- 2021
46. Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction
- Author
-
Hoed, J. den, Boer, E. de, Voisin, N., Dingemans, A.J.M., Guex, N., Wiel, L.J.M. van de, Nellaker, C., Amudhavalli, S.M., Banka, S., Bena, F.S., Ben-Zeev, B., Bonagura, V.R., Bruel, A.L., Brunet, T., Brunner, H.G., Chew, H.B., Chrast, J., Cimbalistienė, L., Coon, H., Délot, E.C., Démurger, F., Denommé-Pichon, A.S., Depienne, C., Donnai, D., Dyment, D.A., Elpeleg, O., Faivre, L., Gilissen, C.F., Granger, L., Haber, B., Hachiya, Y., Abedi, Y.H., Hanebeck, J., Hehir-Kwa, J.Y., Horist, B., Itai, T., Jackson, A., Jewell, R., Jones, K.L., Joss, S., Kashii, H., Kato, M., Kattentidt-Mouravieva, A.A., Kok, F., Kotzaeridou, U., Krishnamurthy, V., Kučinskas, V., Kuechler, A., Lavillaureix, A., Liu, P, Manwaring, L., Matsumoto, N., Mazel, B., McWalter, K., Meiner, V., Mikati, M.A., Miyatake, S., Mizuguchi, T., Moey, L.H., Mohammed, S, Mor-Shaked, H., Mountford, H., Newbury-Ecob, R., Odent, S., Orec, L., Osmond, M., Palculict, T.B., Parker, M., Petersen, A.K., Pfundt, R.P., Preikšaitienė, E., Radtke, K., Ranza, E., Rosenfeld, J.A., Santiago-Sim, T., Schwager, C., Sinnema, M., Snijders Blok, L., Spillmann, R.C., Stegmann, A.P.A., Thiffault, I., Tran, L., Vaknin-Dembinsky, A., Vedovato-Dos-Santos, J.H., Schrier Vergano, S.A., Vilain, E., Vitobello, A., Wagner, M., Waheeb, A., Willing, M., Zuccarelli, B., Kini, U., Newbury, D.F., Kleefstra, T., Reymond, A., Fisher, S.E., Vissers, L.E.L.M., Hoed, J. den, Boer, E. de, Voisin, N., Dingemans, A.J.M., Guex, N., Wiel, L.J.M. van de, Nellaker, C., Amudhavalli, S.M., Banka, S., Bena, F.S., Ben-Zeev, B., Bonagura, V.R., Bruel, A.L., Brunet, T., Brunner, H.G., Chew, H.B., Chrast, J., Cimbalistienė, L., Coon, H., Délot, E.C., Démurger, F., Denommé-Pichon, A.S., Depienne, C., Donnai, D., Dyment, D.A., Elpeleg, O., Faivre, L., Gilissen, C.F., Granger, L., Haber, B., Hachiya, Y., Abedi, Y.H., Hanebeck, J., Hehir-Kwa, J.Y., Horist, B., Itai, T., Jackson, A., Jewell, R., Jones, K.L., Joss, S., Kashii, H., Kato, M., Kattentidt-Mouravieva, A.A., Kok, F., Kotzaeridou, U., Krishnamurthy, V., Kučinskas, V., Kuechler, A., Lavillaureix, A., Liu, P, Manwaring, L., Matsumoto, N., Mazel, B., McWalter, K., Meiner, V., Mikati, M.A., Miyatake, S., Mizuguchi, T., Moey, L.H., Mohammed, S, Mor-Shaked, H., Mountford, H., Newbury-Ecob, R., Odent, S., Orec, L., Osmond, M., Palculict, T.B., Parker, M., Petersen, A.K., Pfundt, R.P., Preikšaitienė, E., Radtke, K., Ranza, E., Rosenfeld, J.A., Santiago-Sim, T., Schwager, C., Sinnema, M., Snijders Blok, L., Spillmann, R.C., Stegmann, A.P.A., Thiffault, I., Tran, L., Vaknin-Dembinsky, A., Vedovato-Dos-Santos, J.H., Schrier Vergano, S.A., Vilain, E., Vitobello, A., Wagner, M., Waheeb, A., Willing, M., Zuccarelli, B., Kini, U., Newbury, D.F., Kleefstra, T., Reymond, A., Fisher, S.E., and Vissers, L.E.L.M.
- Abstract
Contains fulltext : 231687.pdf (Publisher’s version ) (Closed access), Whereas large-scale statistical analyses can robustly identify disease-gene relationships, they do not accurately capture genotype-phenotype correlations or disease mechanisms. We use multiple lines of independent evidence to show that different variant types in a single gene, SATB1, cause clinically overlapping but distinct neurodevelopmental disorders. Clinical evaluation of 42 individuals carrying SATB1 variants identified overt genotype-phenotype relationships, associated with different pathophysiological mechanisms, established by functional assays. Missense variants in the CUT1 and CUT2 DNA-binding domains result in stronger chromatin binding, increased transcriptional repression, and a severe phenotype. In contrast, variants predicted to result in haploinsufficiency are associated with a milder clinical presentation. A similarly mild phenotype is observed for individuals with premature protein truncating variants that escape nonsense-mediated decay, which are transcriptionally active but mislocalized in the cell. Our results suggest that in-depth mutation-specific genotype-phenotype studies are essential to capture full disease complexity and to explain phenotypic variability.
- Published
- 2021
47. Quantitative facial phenotyping for Koolen-de Vries and 22q11.2 deletion syndrome
- Author
-
Dingemans, A.J.M., Stremmelaar, D.E., Donk, R. van der, Vissers, L.E.L.M., Koolen, D.A., Rump, P., Hehir-Kwa, J.Y., Vries, B.B.A. de, Dingemans, A.J.M., Stremmelaar, D.E., Donk, R. van der, Vissers, L.E.L.M., Koolen, D.A., Rump, P., Hehir-Kwa, J.Y., and Vries, B.B.A. de
- Abstract
Contains fulltext : 237899.pdf (Publisher’s version ) (Closed access), The Koolen-de Vries syndrome (KdVS) is a multisystem syndrome with variable facial features caused by a 17q21.31 microdeletion or KANSL1 truncating variant. As the facial gestalt of KdVS has resemblance with the gestalt of the 22q11.2 deletion syndrome (22q11.2DS), we assessed whether our previously described hybrid quantitative facial phenotyping algorithm could distinguish between these two syndromes, and whether there is a facial difference between the molecular KdVS subtypes. We applied our algorithm to 2D photographs of 97 patients with KdVS (78 microdeletions, 19 truncating variants (likely) causing KdVS) and 48 patients with 22q11.2DS as well as age, gender and ethnicity matched controls with intellectual disability (n = 145). The facial gestalts of KdVS and 22q11.2DS were both recognisable through significant clustering by the hybrid model, yet different from one another (p = 7.5 × 10(-10) and p = 0.0052, respectively). Furthermore, the facial gestalts of KdVS caused by a 17q21.31 microdeletion and KANSL1 truncating variant (likely) causing KdVS were indistinguishable (p = 0.981 and p = 0.130). Further application to three patients with a variant of unknown significance in KANSL1 showed that these faces do not match KdVS. Our data highlight quantitative facial phenotyping not only as a powerful tool to distinguish syndromes with overlapping facial dysmorphisms but also to establish pathogenicity of variants of unknown clinical significance.
- Published
- 2021
48. SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females
- Author
-
Radio, F.C., Pang, K., Ciolfi, A., Levy, M.A., Hernández-García, A., Pedace, L., Pantaleoni, F., Liu, Z, Boer, E. de, Jackson, A., Bruselles, A., McConkey, H., Stellacci, E., Cicero, S. Lo, Motta, M., Carrozzo, R., Dentici, M.L., McWalter, K., Desai, M., Monaghan, K.G., Telegrafi, A., Philippe, C., Vitobello, A., Au, M., Grand, K., Sanchez-Lara, P.A., Baez, J., Lindstrom, K., Kulch, P., Sebastian, J., Madan-Khetarpal, S., Roadhouse, C., MacKenzie, J.J., Monteleone, B., Saunders, C.J., Cuevas, J.K. Jean, Cross, L., Zhou, D., Hartley, T., Sawyer, S.L., Monteiro, F.P., Secches, T.V., Kok, F., Schultz-Rogers, L.E., Macke, E.L., Morava, E., Klee, E.W., Kemppainen, J., Iascone, M., Selicorni, A., Tenconi, R., Amor, D.J., Pais, L., Gallacher, L., Turnpenny, P.D., Stals, K., Ellard, S., Cabet, S., Lesca, G., Pascal, J., Steindl, K., Ravid, S., Weiss, K., Castle, A.M.R., Carter, M.T., Kalsner, L., Vries, B.B.A. de, Bon, B.W. van, Wevers, M.R., Pfundt, R.P., Stegmann, A.P.A., Kerr, B., Kingston, H.M., Chandler, K.E., Sheehan, W., Elias, A.F., Shinde, D.N., Towne, M.C., Robin, N.H., Goodloe, D., Vanderver, A., Sherbini, O., Bluske, K., Hagelstrom, R.T., Zanus, C., Faletra, F., Musante, L., Kurtz-Nelson, E.C., Earl, R.K., Anderlid, B.M., Morin, G., Slegtenhorst, M. van, Diderich, K.E.M., Brooks, A.S., Gribnau, J., Boers, R.G., Finestra, T.R., Carter, L.B., Rauch, A., Gasparini, P., Vissers, L.E.L.M., Lloyd Holder, J., Tartaglia, M., Radio, F.C., Pang, K., Ciolfi, A., Levy, M.A., Hernández-García, A., Pedace, L., Pantaleoni, F., Liu, Z, Boer, E. de, Jackson, A., Bruselles, A., McConkey, H., Stellacci, E., Cicero, S. Lo, Motta, M., Carrozzo, R., Dentici, M.L., McWalter, K., Desai, M., Monaghan, K.G., Telegrafi, A., Philippe, C., Vitobello, A., Au, M., Grand, K., Sanchez-Lara, P.A., Baez, J., Lindstrom, K., Kulch, P., Sebastian, J., Madan-Khetarpal, S., Roadhouse, C., MacKenzie, J.J., Monteleone, B., Saunders, C.J., Cuevas, J.K. Jean, Cross, L., Zhou, D., Hartley, T., Sawyer, S.L., Monteiro, F.P., Secches, T.V., Kok, F., Schultz-Rogers, L.E., Macke, E.L., Morava, E., Klee, E.W., Kemppainen, J., Iascone, M., Selicorni, A., Tenconi, R., Amor, D.J., Pais, L., Gallacher, L., Turnpenny, P.D., Stals, K., Ellard, S., Cabet, S., Lesca, G., Pascal, J., Steindl, K., Ravid, S., Weiss, K., Castle, A.M.R., Carter, M.T., Kalsner, L., Vries, B.B.A. de, Bon, B.W. van, Wevers, M.R., Pfundt, R.P., Stegmann, A.P.A., Kerr, B., Kingston, H.M., Chandler, K.E., Sheehan, W., Elias, A.F., Shinde, D.N., Towne, M.C., Robin, N.H., Goodloe, D., Vanderver, A., Sherbini, O., Bluske, K., Hagelstrom, R.T., Zanus, C., Faletra, F., Musante, L., Kurtz-Nelson, E.C., Earl, R.K., Anderlid, B.M., Morin, G., Slegtenhorst, M. van, Diderich, K.E.M., Brooks, A.S., Gribnau, J., Boers, R.G., Finestra, T.R., Carter, L.B., Rauch, A., Gasparini, P., Vissers, L.E.L.M., Lloyd Holder, J., and Tartaglia, M.
- Abstract
Contains fulltext : 231702.pdf (Publisher’s version ) (Closed access), Deletion 1p36 (del1p36) syndrome is the most common human disorder resulting from a terminal autosomal deletion. This condition is molecularly and clinically heterogeneous. Deletions involving two non-overlapping regions, known as the distal (telomeric) and proximal (centromeric) critical regions, are sufficient to cause the majority of the recurrent clinical features, although with different facial features and dysmorphisms. SPEN encodes a transcriptional repressor commonly deleted in proximal del1p36 syndrome and is located centromeric to the proximal 1p36 critical region. Here, we used clinical data from 34 individuals with truncating variants in SPEN to define a neurodevelopmental disorder presenting with features that overlap considerably with those of proximal del1p36 syndrome. The clinical profile of this disease includes developmental delay/intellectual disability, autism spectrum disorder, anxiety, aggressive behavior, attention deficit disorder, hypotonia, brain and spine anomalies, congenital heart defects, high/narrow palate, facial dysmorphisms, and obesity/increased BMI, especially in females. SPEN also emerges as a relevant gene for del1p36 syndrome by co-expression analyses. Finally, we show that haploinsufficiency of SPEN is associated with a distinctive DNA methylation episignature of the X chromosome in affected females, providing further evidence of a specific contribution of the protein to the epigenetic control of this chromosome, and a paradigm of an X chromosome-specific episignature that classifies syndromic traits. We conclude that SPEN is required for multiple developmental processes and SPEN haploinsufficiency is a major contributor to a disorder associated with deletions centromeric to the previously established 1p36 critical regions.
- Published
- 2021
49. Human disease genes website series: An international, open and dynamic library for up-to-date clinical information
- Author
-
Dingemans, A.J.M., Stremmelaar, D.E., Vissers, L.E.L.M., Jansen, S, Nabais Sá, M.J., Remortele, A.M. van, Jonis, N., Truijen, K., Ven, S. van de, Ewals, J., Verbruggen, M., Koolen, D.A., Brunner, H.G., Eichler, E.E., Gecz, J., Vries, B.B.A. de, Dingemans, A.J.M., Stremmelaar, D.E., Vissers, L.E.L.M., Jansen, S, Nabais Sá, M.J., Remortele, A.M. van, Jonis, N., Truijen, K., Ven, S. van de, Ewals, J., Verbruggen, M., Koolen, D.A., Brunner, H.G., Eichler, E.E., Gecz, J., and Vries, B.B.A. de
- Abstract
Contains fulltext : 231730.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
50. Genetic causes of male infertility
- Author
-
Veltman, J.A., Vissers, L.E.L.M., Ramos, L., Oud, M.S., Veltman, J.A., Vissers, L.E.L.M., Ramos, L., and Oud, M.S.
- Abstract
Radboud University, 18 juni 2021, Promotor : Veltman, J.A. Co-promotores : Vissers, L.E.L.M., Ramos, L., Contains fulltext : 233754.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.